{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:16:58Z","timestamp":1793643418805,"version":"4.5.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:00:00Z","timestamp":1715644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013279","name":"National Key New Drug Creation and Manufacturing Program, Ministry of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2018ZX09201017"],"award-info":[{"award-number":["2018ZX09201017"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.tox.2024.153829","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T15:18:48Z","timestamp":1715440728000},"page":"153829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction"],"prefix":"10.1016","volume":"505","author":[{"given":"Baiyang","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihe","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingchao","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.tox.2024.153829_bib1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1124\/dmd.114.058834","article-title":"Expression of hepatic drug-metabolizing cytochrome p450 enzymes and their intercorrelations: a meta-analysis","volume":"42","author":"Achour","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/toxsci\/kfq009","article-title":"Mechanisms of immune-mediated liver injury","volume":"115","author":"Adams","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.tox.2024.153829_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/JLB.1A0521-251R","article-title":"Fatty acids secreted from head and neck cancer induce M2-like macrophages","volume":"112","author":"Albakri","year":"2022","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10565-020-09537-1","article-title":"Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity","volume":"37","author":"Allard","year":"2021","journal-title":"Cell Biol. Toxicol."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"10.1016\/j.tox.2024.153829_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.therap.2018.02.004","article-title":"Safety data and withdrawal of hepatotoxic drugs","volume":"76","author":"Babai","year":"2021","journal-title":"Therapie"},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/toxsci\/kfv159","article-title":"Quantification of drug-induced inhibition of canalicular cholyl-l-lysyl-fluorescein excretion from hepatocytes by high content cell imaging","volume":"148","author":"Barber","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2024.153829_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115279","article-title":"HepG2 (C3A) spheroids show higher sensitivity compared to HepaRG spheroids for drug-induced liver injury (DILI)","volume":"408","author":"Basharat","year":"2020","journal-title":"Toxicol. Appl. Pharm."},{"issue":"9","key":"10.1016\/j.tox.2024.153829_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1089\/ten.tec.2018.0134","article-title":"Three-dimensional spheroid primary human hepatocytes in monoculture and coculture with nonparenchymal cells","volume":"24","author":"Baze","year":"2018","journal-title":"Tissue Eng. Part C. -Me"},{"issue":"4","key":"10.1016\/j.tox.2024.153829_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00204-020-02682-w","article-title":"Functionality of primary hepatic non-parenchymal cells in a 3D spheroid model and contribution to acetaminophen hepatotoxicity","volume":"94","author":"Bell","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2024.153829_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"issue":"6801","key":"10.1016\/j.tox.2024.153829_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.tox.2024.153829_bib13","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1021\/mp4001348","article-title":"Evaluating the in vitro inhibition of UGT1A1, OATP1B1, OATP1B3, MRP2, and BSEP in predicting drug-induced hyperbilirubinemia","volume":"10","author":"Chang","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","article-title":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","volume":"274","author":"Chatterjee","year":"2014","journal-title":"Toxicol. Appl. Pharm."},{"issue":"12","key":"10.1016\/j.tox.2024.153829_bib15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/BF03261997","article-title":"Current challenges and controversies in drug-induced liver injury","volume":"35","author":"Corsini","year":"2012","journal-title":"Drug Saf."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/jpet.110.166991","article-title":"Hepatic transport mechanisms of cholyl-l-lysyl-fluorescein","volume":"334","author":"de Waart","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tox.2024.153829_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev-biophys-042910-155359","article-title":"Actin structure and function","volume":"40","author":"Dominguez","year":"2011","journal-title":"Annu. Rev. Biophys."},{"issue":"19","key":"10.1016\/j.tox.2024.153829_bib18","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.3390\/ijms231911428","article-title":"In vitro models for studying chronic drug-induced liver injury","volume":"23","author":"Donato","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(01)00456-5","article-title":"Regulation of biliary drug efflux pump expression by hormones and xenobiotics","volume":"167","author":"Fardel","year":"2001","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/cpt.2968","article-title":"Physiologically based pharmacokinetic modeling of bergamottin and 6,7-dihydroxybergamottin to describe CYP3A4 mediated grapefruit-drug interactions","volume":"114","author":"Fuhr","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.tox.2024.153829_bib21","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/mp200641e","article-title":"Cationic amphiphilic drugs cause a marked expansion of apparent lysosomal volume: implications for an intracellular distribution-based drug interaction","volume":"9","author":"Funk","year":"2012","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tiv.2013.10.015","article-title":"Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes","volume":"28","author":"Garside","year":"2014","journal-title":"Toxicol. Vitr."},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jhep.2012.03.017","article-title":"Liver transplantation for acute liver failure in Europe: Outcomes over 20 years from the ELTR database","volume":"57","author":"Germani","year":"2012","journal-title":"J. Hepatol."},{"issue":"1 Pt A","key":"10.1016\/j.tox.2024.153829_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tiv.2014.05.009","article-title":"Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatment","volume":"30","author":"Germano","year":"2015","journal-title":"Toxicol. Vitr."},{"issue":"8","key":"10.1016\/j.tox.2024.153829_bib25","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00204-013-1078-5","article-title":"Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME","volume":"87","author":"Godoy","year":"2013","journal-title":"Arch. Toxicol."},{"issue":"92","key":"10.1016\/j.tox.2024.153829_bib26","doi-asserted-by":"crossref","first-page":"20131124","DOI":"10.1098\/rsif.2013.1124","article-title":"A method for estimating the oxygen consumption rate in multicellular tumour spheroids","volume":"11","author":"Grimes","year":"2014","journal-title":"J. R. Soc. Interface"},{"issue":"3","key":"10.1016\/j.tox.2024.153829_bib27","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1124\/dmd.110.035873","article-title":"Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes","volume":"39","author":"Guo","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2024.153829_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol. -Mech."},{"issue":"3","key":"10.1016\/j.tox.2024.153829_bib29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury - types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.tox.2024.153829_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1039\/C6IB00039H","article-title":"Three-dimensional models for studying development and disease: moving on from organisms to organs-on-a-chip and organoids","volume":"8","author":"Jackson","year":"2016","journal-title":"Integr. Biol."},{"issue":"8","key":"10.1016\/j.tox.2024.153829_bib31","doi-asserted-by":"crossref","first-page":"10167","DOI":"10.1021\/acsami.2c00312","article-title":"Mimicking native liver lobule microarchitecture in vitro with parenchymal and non-parenchymal cells using 3D bioprinting for drug toxicity and drug screening applications","volume":"14","author":"Janani","year":"2022","journal-title":"ACS Appl. Mater. Inter."},{"key":"10.1016\/j.tox.2024.153829_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.018","article-title":"Drugs and hepatic transporters: a review","volume":"154","author":"Jetter","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.xphs.2020.10.043","article-title":"Primary human hepatocyte spheroid model as a 3D in vitro platform for metabolism studies","volume":"110","author":"Kanebratt","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.tox.2024.153829_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/clpt.2012.79","article-title":"A perspective on efflux transport proteins in the liver","volume":"92","author":"K\u00f6ck","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/toxsci\/kfz229","article-title":"High-throughput screening to evaluate inhibition of bile acid transporters using human hepatocytes isolated from chimeric mice","volume":"173","author":"Kohara","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/nyas.14798","article-title":"Tight junction proteins occludin and ZO-1 as regulators of epithelial proliferation and survival","volume":"1514","author":"Kuo","year":"2022","journal-title":"Ann. NY Acad. Sci."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/cimm.2001.1824","article-title":"Production of proinflammatory cytokines by resident tissue macrophages after phagocytosis of apoptotic cells","volume":"211","author":"Kurosaka","year":"2001","journal-title":"Cell. Immunol."},{"issue":"17","key":"10.1016\/j.tox.2024.153829_bib38","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","article-title":"Timing of new black box warnings and withdrawals for prescription medications","volume":"287","author":"Lasser","year":"2002","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib39","doi-asserted-by":"crossref","first-page":"7296","DOI":"10.1038\/s41467-023-43109-1","article-title":"Structural basis of bile salt extrusion and small-molecule inhibition in human BSEP","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tox.2024.153829_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114400","article-title":"Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury","volume":"160","author":"Liu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.tox.2024.153829_bib41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jim.2016.01.012","article-title":"The choice of phorbol 12-myristate 13-acetate differentiation protocol influences the response of THP-1 macrophages to a pro-inflammatory stimulus","volume":"430","author":"Lund","year":"2016","journal-title":"J. Immunol. Methods"},{"issue":"Pt 1)","key":"10.1016\/j.tox.2024.153829_bib42","article-title":"Application of triple co-cultured cell spheroid model for exploring hepatotoxicity and metabolic pathway of AFB1","volume":"807","author":"Ma","year":"2022","journal-title":"Sci. Total Environ."},{"issue":"6","key":"10.1016\/j.tox.2024.153829_bib43","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1084952102001301","article-title":"The role of non-parenchymal cells in liver growth","volume":"13","author":"Malik","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bdd.527","article-title":"Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance-associated protein 2","volume":"28","author":"Mano","year":"2007","journal-title":"Biopharm. Drug Dispos."},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0304-4165(91)90024-B","article-title":"Cholyl-lysylfluorescein: synthesis, biliary excretion in vivo and during single-pass perfusion of isolated perfused rat liver","volume":"1115","author":"Mills","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res."},{"issue":"4","key":"10.1016\/j.tox.2024.153829_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003330","article-title":"IL-1\u03b2 production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease","volume":"9","author":"Negash","year":"2013","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/rtph.2000.1399","article-title":"Concordance of the toxicity of pharmaceuticals in humans and in animals","volume":"32","author":"Olson","year":"2000","journal-title":"Regul. Toxicol. Pharm."},{"key":"10.1016\/j.tox.2024.153829_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tiv.2016.03.008","article-title":"Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes","volume":"34","author":"Oorts","year":"2016","journal-title":"Toxicol. Vitr."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00011-007-6115-5","article-title":"Optimized THP-1 differentiation is required for the detection of responses to weak stimuli","volume":"56","author":"Park","year":"2007","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.tox.2024.153829_bib51","article-title":"Macrophage mertk promotes profibrogenic cross-talk with hepatic stellate cells via soluble mediators","volume":"4","author":"Pastore","year":"2022","journal-title":"JHEP Rep."},{"issue":"7","key":"10.1016\/j.tox.2024.153829_bib52","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.3390\/ijms20071629","article-title":"Human multilineage 3D spheroids as a model of liver steatosis and fibrosis","volume":"20","author":"Pingitore","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.tox.2024.153829_bib53","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"2 Suppl 1","key":"10.1016\/j.tox.2024.153829_bib54","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.tox.2024.153829_bib55","first-page":"1083","article-title":"A 3d in vitro model of differentiated hepg2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies","volume":"88","author":"Ramaiahgari","year":"2014","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tox.2024.153829_bib56","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/978-1-4939-9420-5_20","article-title":"Organotypic 3D HepaRG liver model for assessment of drug-induced cholestasis","volume":"1981","author":"Ramaiahgari","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib57","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfx122","article-title":"From the cover: Three-dimensional (3D) HepaRG spheroid model with physiologically relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening","volume":"159","author":"Ramaiahgari","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13046-017-0570-9","article-title":"Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids","volume":"36","author":"Riffle","year":"2017","journal-title":"J. Exp. Clin. Canc. Res."},{"issue":"3","key":"10.1016\/j.tox.2024.153829_bib59","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.drudis.2013.11.014","article-title":"Reducing attrition in drug development: smart loading preclinical safety assessment","volume":"19","author":"Roberts","year":"2014","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.tox.2024.153829_bib60","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/cmi.2016.3","article-title":"Liver immunology and its role in inflammation and homeostasis","volume":"13","author":"Robinson","year":"2016","journal-title":"Cell Mol. Immunol."},{"issue":"4","key":"10.1016\/j.tox.2024.153829_bib61","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.tox.2024.153829_bib62","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/lt.20204","article-title":"Liver transplantation for acute liver failure from drug induced liver injury in the United States","volume":"10","author":"Russo","year":"2004","journal-title":"Liver Transpl."},{"issue":"2","key":"10.1016\/j.tox.2024.153829_bib63","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","article-title":"Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in vitro assays","volume":"147","author":"Shah","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"3-4","key":"10.1016\/j.tox.2024.153829_bib64","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.drudis.2008.11.009","article-title":"The future of drug safety testing: expanding the view and narrowing the focus","volume":"14","author":"Stevens","year":"2009","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/pharmaceutics15010029","article-title":"Role of hepatocyte transporters in drug-induced liver injury (DILI)-in vitro testing","volume":"15","author":"T\u00e1trai","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib66","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00204-017-2036-4","article-title":"Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury","volume":"92","author":"Tolosa","year":"2018","journal-title":"Arch. Toxicol."},{"issue":"23","key":"10.1016\/j.tox.2024.153829_bib67","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1007\/s00018-008-8281-1","article-title":"The cell-cell adhesion molecule E-cadherin","volume":"65","author":"van Roy","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.tox.2024.153829_bib68","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.tox.2024.153829_bib69","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nrc3064","article-title":"Targeting hypoxia in cancer therapy","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/gut.2004.042127","article-title":"Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis","volume":"54","author":"Xu","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.tox.2024.153829_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway.","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell Proliferat"},{"key":"10.1016\/j.tox.2024.153829_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2019.104449","article-title":"Characterization of in vitro MRP2 transporter model based on intestinal organoids","volume":"108","author":"Zhang","year":"2019","journal-title":"Regul. Toxicol. Pharm."},{"issue":"4","key":"10.1016\/j.tox.2024.153829_bib73","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/10408444.2020.1756219","article-title":"Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation","volume":"50","author":"Zhang","year":"2020","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tox.2024.153829_bib74","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.taap.2018.04.016","article-title":"Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis","volume":"348","author":"Zhang","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"issue":"10","key":"10.1016\/j.tox.2024.153829_bib75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1124\/dmd.120.000076","article-title":"Detection of weak organic anion-transporting polypeptide 1B inhibition by probenecid with plasma-based coproporphyrin in humans","volume":"48","author":"Zhang","year":"2020","journal-title":"Drug Metab. Dispos."},{"issue":"23","key":"10.1016\/j.tox.2024.153829_bib76","doi-asserted-by":"crossref","first-page":"12808","DOI":"10.3390\/ijms222312808","article-title":"Cytochrome p450 enzymes and drug metabolism in humans","volume":"22","author":"Zhao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tox.2024.153829_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2022.123262","article-title":"Design and fabrication of an integrated 3D dynamic multicellular liver-on-a-chip and its application in hepatotoxicity screening","volume":"241","author":"Zheng","year":"2022","journal-title":"Talanta"}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24001100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X24001100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T21:01:52Z","timestamp":1737752512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X24001100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":77,"alternative-id":["S0300483X24001100"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2024.153829","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2024.153829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153829"}}